menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Keys to Managing Myelosuppressive Events in SCLC: A Review of the NCCN Guidelines

ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Media formats available:
Completing the pre-test is required to view this content.
Completing the pre-survey is required to view this content.
Details
Presenters
  • Sponsored by

  • Overview

    When it comes to managing chemotherapy-induced myelosuppressive events, what do the NCCN guidelines recommend? Dr. Jacobs Sands joins Dr. Millie Das, Chief of Oncology at the Palo Alto V.A. and a Clinical Associate Professor of Medicine and Oncology at Stanford University, to discuss the latest guideline updates in care for patients with small cell lung cancer.

Recommended
Details
Presenters
  • Sponsored by

  • Overview

    When it comes to managing chemotherapy-induced myelosuppressive events, what do the NCCN guidelines recommend? Dr. Jacobs Sands joins Dr. Millie Das, Chief of Oncology at the Palo Alto V.A. and a Clinical Associate Professor of Medicine and Oncology at Stanford University, to discuss the latest guideline updates in care for patients with small cell lung cancer.

Schedule12 Aug 2022
Webpack App